Monthly Archives: May 2015

29 May 2015

Symetrica – Parkwalk closes follow on investment

By |May 29th, 2015|

We are pleased to announce that the Parkwalk UK Tech Fund VI has led a financing round into Symetrica, who specialize in the detection and identification of radioisotopes for Security Applications.

The company works with prime contractors and government agencies to design, develop, test and deploy detection equipment for use by law enforcement personnel, customs officers, the […]

Parkwalk closes Mirriad investment

By |May 19th, 2015|

We are pleased to announce that Parkwalk have closed an investment into Mirriad, the leading provider of NIVA (Native In-Video Advertising) services to brands and agencies looking to address the growing challenges presented by ad skipping and ad blindness. The Mirriad technology was originally developed at Surrey University,

Mirriad claims to have the most integrated set of […]

Oxbridge spin-out event

By |May 15th, 2015|

Parkwalk are delighted to have sponsored the first joint Oxford and Cambridge University spin-out investor event, which was held at the London Stock Exchange yesterday.
Dame Carol Robinson, the first female professor of chemistry at both Oxford and Cambridge universities, gave an excellent speech on her work in mass spectrometry and there were great presentations by:

Bodle Technologies […]

Parkwalk closes Cisiv investment

By |May 8th, 2015|

We are pleased to announce that the Parkwalk Opportunities EIS Fund and the Parkwalk UK Tech Fund V have led a financing round into Cisiv, an innovative and intuitive software platform for late phase pharmaceutical trials. enables pharmaceutical customers to capture, analyse and share patient data quickly, simply and effectively.

Cisiv has been a pioneering […]

Fuel 3D – Secures Investment From IQT For 3D Scanning Technology Development

By |May 6th, 2015|

Fuel3D, a developer of 3D scanning solutions, today announced a strategic investment and technology development agreement with In-Q-Tel (IQT), the not-for-profit investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community (IC).
“The speed with which we capture high resolution 3D data is key to what makes Fuel3D’s technology […]

Parkwalk appoints Chairman

By |May 6th, 2015|

Parkwalk are delighted to announce that Gordon Lawson has been appointed non-executive Chairman of Parkwalk.
Gordon has 30 years City experience, as head of equity proprietary trading and EMEA equity, derivatives and convertible bond risk at Salomon/Citigroup and then as the founder of Pendragon Capital, the event-driven hedge fund.
He is an adviser to several hedge funds, […]

Horizon Discovery – Placing to raise approximately £25 million to accelerate the Company’s growth strategy

By |May 1st, 2015|

Horizon Discovery Group plc (LSE:HZD), the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, is pleased to announce a conditional non-pre-emptive placing of 13,157,895 New Placing Shares at a Placing Price of 190 pence per share to raise approximately £25.0 million before expenses. […]

Parkwalk closes Sphere Medical investment

By |May 1st, 2015|

We are pleased to announce that the Parkwalk Opportunities EIS Fund has participated in a £13m financing round into the AIM-listed Sphere Medical Holdings plc. The financing round was led by Woodford’s Patient Capital Trust plc and Chris Evans’ Arthurian Life Sciences Fund.

Sphere Medical is a dynamic company specialising in the development of innovative […]